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ening of their clinical status had an overall mortality at 6 months of 25%, and
at 1 year of 63%.
Conclusions: 1) Arrhythmic storm is associated with a poor prognosis in
nonischemic pts, 2) The triggering factors include mainly the deterioration of
the clinical status.
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Introduction: The coexistence of Mahaim fibbers (MF) and hypertrophic
cardiomyopathy (HCM) is exceptional. We report an unusual case of a young
female patient presenting with HCM and MF. 
Case-report: A 17 y/o woman was referred in 1998 for a familial HCM
screening. She had no symptoms; her surface EKG revealed a preexcitation
suggesting a right anteroseptal WPW syndrome. The transthoracic echocardio-
gram (TTE) demonstrated an asymmetric septal HCM without LV outflow
tract (LVOT) obstruction. The electrophysiological study (EPS) demonstrated
the presence of MF (normal AH interval, a short and fixed HV interval and
atrial pacing produced AH prolongation without change of preexcitation
degree, indicating fasciculo-ventricular MF). 
Eight years later (25 y/o) while the patient was doing well, the ECG was
similar and TEE demonstrated the same aspect of asymmetric septal HCM
without obstruction. Three months later the patient was pregnant and gave
birth to a healthy baby. (During pregnancy: Delta wave was present and there
was no LVOT obstruction). After delivery, Surprisingly there was no more
preexcitation on her ECG and the TEE demonstrated now a significant LVOT
obstruction with a systolic anterior motion of the mitral valve and an LVOT
gradient of 36 mmHg. A second EPS was performed in 2008 and showed no
more preexcitation. We speculate the hypothesis that FV fiber played in this
case a similar pathogenic role as does the apical right ventricular pacing when
it is used to decrease LVOT gradient in patients with HCM.
Conclusion: This case deserves to be reported because the association of
MF and HCM is rare (only 3 cases reported in english litterature), the disap-
pearance of MF during pregnancy has never been reported and the hypothesis
that the RV preexcitation via FV Mahaim fiber played a role in decreasing
LVOT gradient in this patient with HCM.
211
Clinical value of left atrial appendage flow for prediction of successful
catheter ablation for persistent atrial fibrillation
Stephane Combes, Jean Paul Albenque, Sophie Jacob, Arnaud Chaumeil,
Nicolas Combes, Antoine Deplagne, Serge Boveda, Jean Pierre Donzeau
Clinique Pasteur, Rythmologie, Toulouse, France
Introduction: The purpose of this study was to determine whether left
atrial appendage flow velocity, as determined using trans esophageal echocar-
diography (TEE), predicts the outcome after catheter ablation of persistent
atrial fibrillation( PAF).
Method: 40 PAF patients (85% males, 60 +/- 11 years) underwent a step-
wise ablation approach. The procedural end point was termination of persistent
AF by catheter ablation, either by conversion directly to sinus rhythm or to
atrial tachycardia. Left atrial appendage (LAA) peak flow velocities were mea-
sured with transesophageal echography and averaged within each RR interval
of 10 consecutive cardiac cycles. Others parameters LA area, left ventricular
ejection fraction, duration of continuous AF, Administration of amiodarone,
were analyzed to determine the factors associated with procedural termination
of arrhythmia. 
Results: Among the 40 patients, all received a circumferential PV isolation, a
linear ablation, and a continuous CFE ablation. Atrial fibrillation was terminated
in 26 patients (65%) with a mean procedure time of 201 min+/-43 min. The pre-
procedural ejection fraction (p = 0.38), duration of continuous AF (p = 0.09) did
not differ significantly between patients who had success of catheter ablation com-
pared with those who had not. Peak emptying velocities of the LAA before cath-
eter ablation were significantly higher in patients in whom PAF was terminated
during the procedure (0.23 vs. 0.34, p = 0.002). On multivariate logistic regression
analysis, only the mean LAA peak emptying velocity > 0.30 cm/s (p = 0.02, odds
ratio [OR] = 9, 58 confidence interval [CI] 95% = 1.50 to 61.36), predicted suc-
cessful catheter ablation for PAF. At 6 months follow-up, patients who underwent
continued to have sinus rhythm, were significantly (p= 0, 003) higher in group
who have LAA flow velocity > 0, 30.
Conclusion: High LAA flow velocity assessed by TEE is a clinically
useful pre-ablation tool for predicting successful catheter ablation for persis-
tent atrial fibrillation and maintenance of sinus rhythm.
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Introduction: Dual-chamber (DC) pacing benefits are impaired by the
occurrence of atrial arrhythmias (AA). Pacemakers (PM) have been enhanced
by a mode-switch function (MSF) which allows the switch from DDD(R) to
DDIR pacing in presence of AA.
Materials and methods:  We analyzed MSF at 6 and 12-month (m)
follow-up in 369 patients (Pts) aged 77+/-9 y, free of permanent AA (59%),
implanted with Kappa® DC PMs (Medtronic, MN, USA) for II and III AV
block (65%), and sinus dysfunction (SD) (35%). 52% had no cardiopathy and
there was no difference in electrical parameters at implant regardless lead and
indication.
No specific programming was imposed. MS function data was collected at
each follow-up: number of MS, average percentage of time in AA. EGM was
used to confirm AA in most cases. 
Results: The MSF shows AA episode rate of 61% at 6 m and 48% at 12
m. Moreover, 29% of pts (Gr1) had no AA during the 12 m, 11% had AA only
during the last 6 m (Gr2), 24% only during the first 6 m (Gr3 and Gr5) and
37% during the 12 m (Gr4 and Gr6). Statistically, there was no significant dif-
ference between groups concerning the number of MS and between the per-
centage of time in AA at each follow-up .
Discussion: Long-term follow-up confirms results already described in the
literature, and the MS event counters may predict the existence of AA.  EGM
confirms the specificity of this function. Number of MS is significantly high
in SD (p<0.05), whereas the observation of a high number of MS may also
point to oversensitivity of the MSF. Percentage time spent in AA is a revealing
parameter, as it represents average time during which pts had been in AA
since the previous follow-up. 
Conclusion: This study confirms that AA occurrence remains an important
complication in PM patients, regardless indication. Simple examination of MS
recordings can lead to suspicion of major AA. The gravity of this AA can be
quickly determined, but only detailed examination of MS episodes can con-
firm the diagnosis.
213
Transseptal implantation of a left ventricular pacing lead for an ecto-
pic location of the CS ostium in the left atrium
P Mondoly (1), M Marrachet (2), A Hebrard (1), A Duparc (1), P Rumeau
(1), P Massabuau (3), M Delay (1), Didier Carrié (2), Ph Maury (1)
(1) Rangueil Hospital, Rythmology and Cardiac Pacing, Toulouse, France
- (2) CHU Rangueil, Pôle Cardio-Vasculaire et Métabolique, Toulouse,
France 
Background: The success rate of left ventricular (LV) lead implantation
for cardiac resynchronization therapy (CRT) is high. Congenital abnormalities
of the coronary sinus (CS) are rare but can be responsible for unsuccessful
implantation. 
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Method and result: A 64-year-old male with standard indication for CRT
was referred to our institution for a CRT-D implantation. Unfortunately, intu-
bation of the CS was not possible. TEE showed a congenital CS anomaly with
complete drainage of the CS into the left atrium.
Because of contra-indication for general anaesthesia and thus for surgical epi-
cardial implantation, we proposed to implant the LV lead by a transseptal
approach.
After the patient had given his consent, a transseptal puncture was performed
via the right femoral vein. A conventional screw-in lead was implanted at the
laterobasal segment of the LV using a deflectable catheter guide introduced
via the left subclavian vein through the transseptal puncture. Post-implantation
parameters of the LV lead were acceptable: pacing threshold 0.7 V-0.4 ms,
impedance 435 ohms, R wave amplitude 5 mvolts. Right ventricular and right
atrium leads were then implanted (fig1)
A post-implant CT scan confirmed the ectopic location of the CS ostium
without persistent superior vena cava (fig 2).
The patient was discharged on anticoagulation with a targeted international
normalized ratio between 3 and 4. At the one- and three-month follow-up, no
complication had occurred. He was in class 2 of the NYHA and had not been
hospitalised. Electrical parameters remained steady.
Conclusion: Complete drainage of the CS in the left atrium without persis-
tent vena cava is a rare congenital abnormality. When cardiac resynchroniza-
tion therapy is needed, transseptal implantation could be a feasible alternative.
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Background: In the long QT syndrome (LQTS) the clinical efficacy of
beta-blocker treatment differs according to the genotype. We aimed to asses
the effect of beta-blocker treatment in LQT1 and LQT2 patients.
Patients and methods: 24-hour Holter ECG were recorded before and
after beta-blocking therapy initiation in genotyped LQT1 (n=30, 8 males,
mean age 21±17) and LQT2 patients (n=16, 8 males, mean age 19±15). QT
duration was measured on consecutive 1-minute averaged QRS-T complexes
leading to up to 1440 QT-RR pairs for each recording. Then, we computed
subject- and condition-specific log/log QT/RR relationships which were used
to calculate QT interval duration at RR=1000 ms (QT1000=1000*).
Results: Before treatment,  coefficients were higher in LQT2 than in LQT1
patients (0.53±0.10 vs. 0.40±0.11, p<0.001) and QT1000 was longer in LQT2
than in LQT1 patients (521±38 vs. 481±39 ms, p<0.01). 
Beta-blockers significantly prolonged the mean RR interval (RR=827±161
ms before treatment and 939±197 ms on beta-blocker, p<0.0001). The  coef-
ficients were not significantly modified by beta-blockers (0.41±0.9 in LQT1
patients and 0.52±0.12 LQT2 patients). Beta-blocker treatment was associated
with a prolongation of the QT1000 interval (from 481±39 to 498±43 ms,
p<0.01) in LQT1 patients but with a shortening in LQT2 patients (from
521±38 to 503±32 ms, p<0.01).  
Conclusions: Our results confirm the elevated coefficient of the QT/RR
relationship in LQTS patients. LQT2 patients showed higher coefficient and
longer QT1000 when compared to LQT1 patients. The effect of beta-adren-
ergic blockade on QT1000 duration was gene-specific. Given the demon-
strated efficacy of beta-blockers in LQT1 and 2 patients, our data suggest that
QT1000 might be a poor predictor of outcome under anti-adrenergic therapy. 
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Accessory pathway (AP) refractory period (RP) increases from the youth to
the elderly. The large indications of AP ablation have changed the natural
follow-up. The purpose of the study was to report the clinical and electrophys-
iological data of pts with a Wolff-Parkinson White syndrome (WPW), studied
within 1 to 20 years of one another to evaluate the changes of these data. 
Methods: 2 baseline EPS were performed within 1 to 20 years  (y) of one
another (mean 9 y ± 4) in 61 pts, 37 males and 24 females, aged initially from
10 to 67 y (30±14), with a patent WPW. First electrophysiological study (EPS)
was indicated for syncope (n=6), atrioventricular reentrant tachycardias
(AVRT) (n=34), atrial fibrillation (AF) (n=5) or for asymptomatic preexcita-
tion (n= 16). The protocol was similar: the higher rate conducted through AP
Figures 1 and 2
